sacituzumab
gilead sciences
['sacitu, govi', 'bcsm', 'sacituzumab', 'breast']
from #esmo22: sacituzumab govitecan improves overall survival vs physician's choice of therapy in hr+/her2- advanced breast cancer. #bcsm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.